ESC/EAS 2025 Update Brings New Recommendations on Cholesterol Management and Risk Assessment
Belgium: The European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) have released a 2025 Focused Update to their 2019 Guidelines for the management ofdyslipidaemias, introducing crucial revisions and new recommendations based on recent scientific evidence. The update, published in theEuropean Heart Journal,aims to refine approaches tocardiovascular (CV) riskassessment and lipid-lowering therapies, particularly ahead of the next comprehensive guideline revision.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!